文献速递关节外科

外科医生手术量对骨水泥与非骨水泥单髁膝关节置换相对翻修率的影响

The Effect of Surgeon Caseload on the Relative Revision Rate of Cemented and Cementless Unicompartmental Knee Replacements: An Analysis from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man.
PubMed 文献 · J Bone Joint Surg Am · 2020-01-01

基于英国国家关节登记系统40,522例Oxford单髁膝关节置换数据,将14,814例(骨水泥与非骨水泥各7,407例)进行倾向评分匹配,分析医生手术量对相对翻修风险的影响。匹配后非骨水泥假体10年生存率仍显著高于骨水泥假体(HR=0.76,p=0.002),且在各手术量组中非骨水泥翻修率均更低;低手术量医生翻修率最高。

要点

  • 非骨水泥固定使翻修率降低约四分之一,不受医生手术量影响。
  • 低手术量医生(<10例/年)无论骨水泥或非骨水泥固定翻修率均高。
  • 高手术量医生(≥30例/年)非骨水泥单髁10年生存率达97.5%。

核心结论

  • 非骨水泥固定使单髁膝关节置换翻修率降低约四分之一,且不受医生手术量影响。
  • 医生手术量对假体生存率有显著影响,低手术量医生翻修率高,高手术量医生非骨水泥单髁10年生存率达97.5%。

研究设计与样本

  • 回顾性登记系统分析,数据来自英国国家关节登记系统,纳入40,522例Oxford单髁膝关节置换(骨水泥30,814例,非骨水泥9,708例)。
  • 将14,814例(骨水泥与非骨水泥各7,407例)进行倾向评分匹配,医生按年手术量分为低量(<10例/年)、中量(10至<30例/年)和高量(≥30例/年)三组,采用Cox回归评估手术量对相对翻修风险的影响。

主要发现

  • 未匹配队列中,非骨水泥与骨水泥单髁10年生存率分别为93.3%(95%CI 89.8%–95.7%)和89.1%(95%CI 88.6%–89.6%),差异显著(HR=0.59;p<0.001)。
  • 非骨水泥假体使用者中高手术量医生比例高于骨水泥假体(30.4%对15.1%)。
  • 匹配后,非骨水泥与骨水泥单髁10年生存率分别为93.2%(95%CI 89.7%–95.6%)和90.2%(95%CI 87.5%–92.3%),差异仍显著(HR=0.76;p=0.002)。
  • 匹配后低手术量医生组非骨水泥与骨水泥10年生存率分别为86.8%(95%CI 73.6%–93.7%)和81.8%(95%CI 73.0%–88.0%);中手术量组分别为94.3%(95%CI 92.2%–95.9%)和92.5%(95%CI 89.9%–94.5%);高手术量组分别为97.5%(95%CI 96.5%–98.2%)和94.2%(95%CI 90.8%–96.4%)。
  • 三个手术量组中非骨水泥假体翻修率均更低(HR分别为0.74、0.79、0.80)。

关键数值与推荐

  • 推荐条款未在原文中报告。

临床怎么用

  • 低手术量医生(<10例/年)无论使用骨水泥或非骨水泥固定,单髁翻修率均高,应考虑停止或增加单髁手术量。
  • 高手术量医生使用非骨水泥单髁可获得与最佳全膝关节置换相仿的10年生存率(97.5%)。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Unicompartmental knee replacement (UKR) offers substantial benefits compared with total knee replacement (TKR) but is associated with higher revision rates. Data from registries suggest that revision rates for cementless UKR implants are lower than those for cemented implants. It is not known how much of this difference is due to the implant or to other factors, such as a greater proportion of high-volume surgeons using cementless implants. We aimed to determine the effect of surgeon caseload on the revision rate of matched cemented and cementless UKRs. METHODS: From a group of 40,522 Oxford (Zimmer Biomet) UKR implants (30,814 cemented, 9,708 cementless) recorded in the National Joint Registry, 14,814 (7,407 cemented, 7,407 cementless) were propensity-score matched. Surgeons were categorized into 3 groups: low volume (<10 cases/year), medium volume (10 to <30 cases/year), and high volume (≥30 cases/year). The effect of caseload on the relative risk of revision was assessed with use of Cox regression. RESULTS: The 10-year survival rates for unmatched cementless and cemented UKR implants were 93.3% (95% confidence interval [CI] = 89.8% to 95.7%) and 89.1% (95% CI = 88.6% to 89.6%), respectively, with the difference being significant (hazard ratio [HR] = 0.59; p < 0.001). Cementless UKR implants had a greater proportion of high-volume surgeon users than cemented implants (30.4% compared with 15.1%). Following matching, the 10-year survival rates were 93.2% (95% CI = 89.7% to 95.6%) and 90.2% (95% CI = 87.5% to 92.3%), which were still significantly different (HR = 0.76; p = 0.002). The 10-year survival rates for matched cementless and cemented UKR implants were 86.8% (95% CI = 73.6% to 93.7%) and 81.8% (95% CI = 73.0% to 88.0%) for low-volume surgeons, 94.3% (95% CI = 92.2% to 95.9%) and 92.5% (95% CI = 89.9% to 94.5%) for medium-volume surgeons, and 97.5% (95% CI = 96.5% to 98.2%) and 94.2% (95% CI = 90.8% to 96.4%) for high-volume surgeons. The revision rate for cementless implants was lower for surgeons in all 3 caseload groups (HR = 0.74, 0.79, 0.80, respectively). CONCLUSIONS: Cementless fixation decreased the revision rate by about a quarter, whatever the surgeon caseload. Caseload had a profound effect on implant survival. Low-volume surgeons had a high revision rate with cemented or cementless fixation and therefore should consider either stopping or doing more UKR procedures. High-volume surgeons performing cementless UKR demonstrated a 10-year survival rate of 97.5%, which was similar to that reported in registries for the best-performing TKRs. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Mohammad HR, Matharu GS, Judge A, et al. The Effect of Surgeon Caseload on the Relative Revision Rate of Cemented and Cementless Unicompartmental Knee Replacements: An Analysis from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man. J Bone Joint Surg Am. 2020. PMID: 32004190. doi:10.2106/JBJS.19.01060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。